Nu Skin Enterprises (NUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 186,883 | 227,751 | 224,250 | 212,532 | 256,057 |
| Marketable Securities | 11,111 | 10,077 | 8,671 | 8,674 | 11,759 |
| Receivables | 50,784 | 68,812 | 71,554 | 67,041 | 58,695 |
| Inventories | 190,242 | 247,789 | 243,994 | 265,100 | 279,978 |
| Other current assets | 26,936 | 0 | 0 | 0 | 14,316 |
| TOTAL | $538,599 | $653,371 | $654,406 | $647,260 | $701,871 |
| Non-Current Assets | |||||
| PPE Net | 379,595 | 410,673 | 411,918 | 422,818 | 432,965 |
| Intangibles | 157,903 | 185,151 | 188,349 | 332,701 | 313,426 |
| Other Non-Current Assets | 392,817 | 333,700 | 331,299 | 339,136 | 360,364 |
| TOTAL | $930,315 | $929,524 | $931,566 | $1,094,655 | $1,106,755 |
| Total Assets | $1,468,914 | $1,582,895 | $1,585,972 | $1,741,915 | $1,808,626 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 30,000 | 60,000 | 30,000 | 30,000 | 25,000 |
| Accounts payable and accrued liabilities | 34,880 | 32,736 | 36,305 | 32,237 | 43,113 |
| Accrued Expenses | 217,808 | 246,615 | 242,288 | 247,068 | 253,702 |
| Other current liabilities | 13,919 | N/A | N/A | N/A | 7,056 |
| TOTAL | $296,607 | $339,351 | $308,593 | $309,305 | $328,871 |
| Non-Current Liabilities | |||||
| Long Term Debt | 363,613 | 373,470 | 428,327 | 453,183 | 478,040 |
| Other Non-Current Liabilities | 157,239 | 163,199 | 162,888 | 169,221 | 179,747 |
| TOTAL | $520,852 | $536,669 | $591,215 | $622,404 | $657,787 |
| Total Liabilities | $817,459 | $876,020 | $899,808 | $931,709 | $986,658 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,723 | 49,711 | 49,702 | 49,667 | 49,421 |
| Common Shares | 91 | 91 | 91 | 91 | 91 |
| Retained earnings | 1,711,949 | 1,751,037 | 1,745,718 | 1,866,958 | 1,870,470 |
| Other shareholders' equity | -124,372 | -104,918 | -117,085 | -110,549 | -100,446 |
| TOTAL | $651,455 | $706,875 | $686,164 | $810,206 | $821,968 |
| Total Liabilities And Equity | $1,468,914 | $1,582,895 | $1,585,972 | $1,741,915 | $1,808,626 |